Sunday, October 2, 2022

FDA shortens Modern Booster time to 5 months

January 10, 2022 — The FDA on Friday shortened the time people receiving Moderna’s COVID-19 vaccine need to wait for a booster — from six months to five months.

That means Americans age 18 and older who received a second shot of the two-dose Moderna Vaccine at least five months ago can now get a third dose.

“The country is in the midst of a wave of the highly infectious Omicron variant, which spreads more rapidly than the original SARS-CoV-2 virus and other forms,” ​​says Peter Marks, MD, director of the FDA’s Center for Biologics. evaluation and research, said in a statement.

“Vaccination is our best defense against COVID-19, including circulating variants, and reducing the time between completion of a primary series and a booster dose can help reduce weakened immunity,” he said. is,” he said.

The most commonly reported side effects for Moderna’s booster dose are pain, redness and swelling at the injection site, the FDA said in the announcement, as well as fatigue, headache, chills and muscle or joint pain.

On Friday afternoon, the CDC director, Rochelle Valensky, MD, said she also approved shortening the timeline for the Moderna booster dose, according to CNN. The CDC’s Vaccine Advisory Committee recommended the FDA’s decision, and it signed off on it.

Earlier this week, the FDA shortened the timeline for Pfizer’s COVID-19 vaccine booster. Now people 12 years of age and older can receive a third dose of the Pfizer vaccine after five months. The CDC also supported the FDA’s decision for the Pfizer booster.

The most commonly reported side effects for Pfizer’s booster dose are the same as for Moderna’s booster, such as pain, redness and swelling at the injection site, the FDA said, as well as fatigue, headache, chills and discoloration of muscles or joints. Of note, swollen lymph nodes in the underarm were more frequent for the Pfizer booster dose than after the second dose.

“During the pandemic, as the virus that causes COVID-19 has continually evolved, the need for the FDA to adapt quickly has meant the use of the best available science to make informed decisions taking into account the health and safety of the American public.” use,” Janet Woodcock, MD, acting FDA commissioner, said in a statement.

“With the current wave of the Omicron variant, it is critical that we continue to take effective, life-saving preventive measures such as primary vaccinations and boosters, wearing masks and social distancing to effectively fight COVID-19,” she said.

The FDA and CDC still recommend that people who have received Johnson & Johnson’s single-dose vaccine should get a booster dose after two months.

According to the latest CDC statistics, about 79% of Americans age 5 and older have received at least one dose of the COVID-19 vaccine, and 66% are fully vaccinated. About 38% of adults have received a booster dose, including about 60% of those 65 years of age and older who are considered most vulnerable to severe COVID-19.

,

Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -